Form D · Other Health Care
Jutiso, Inc.
Washington, DC · CIK 0001958939
Offering snapshot reported May 17, 2024 · SEC filing
- Reported sold
- $12.6M Offering amount: $14.3M
- Investors reported
- 28 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 15, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 17, 2024 | Initial | $12,627,101 | No comparison | 28 | SEC filing |
| Mar 14, 2023 | Initial | $840,000 | No comparison | 3 | SEC filing |
| Dec 19, 2022 | Initial | $710,473 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-513652
Source: Form D, filed May 17, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kristina Beilinson | Director, Executive |
| Kristina Beilinson Keshani | Director, Executive |
| Julia Cole | Executive |
| Mar Hershenson | Director |
| Sophia Richter | Director, Executive |
| Alice Zheng | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
700 K Street Nw, Suite 300
Washington, DC, 20001
Washington, DC, 20001